Immunotherapy for Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) is characterized by extensive tumor heterogeneity at both the pathologic and molecular levels, particularly accelerated aggressiveness, and terrible metastasis. It is responsible for the increased mortality of breast cancer patients. Due to the negative expressio...
Bewaard in:
| Hoofdauteurs: | , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI AG
2021-11-01
|
| Reeks: | Pharmaceutics |
| Onderwerpen: | |
| Online toegang: | https://www.mdpi.com/1999-4923/13/12/2003 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|